|Articles|February 15, 2003
- BioPharm International-02-01-2003
- Volume 16
- Issue 2
The Double Helix at 50: A Half Century of Innovation in the Words of Eight Distinguished Scientists
Author(s)Patrick Clinton
by Patrick Clinton , BioPharm International A BioPharm International Forum
Advertisement
Articles in this issue
almost 23 years ago
Becoming a Partner of Choice and Evaluating Prospective Alliancesalmost 23 years ago
Guest Editorial: Maybe You Need a Corporate Marriage Counseloralmost 23 years ago
Inside Washington: AIDS Prevention Campaign Spotlights Biotechalmost 23 years ago
Survival Strategies: Keeping Tabs on Trainingalmost 23 years ago
Biotech World: Contract Manufacturing: Diversity in the European Marketplacealmost 23 years ago
Outsourcing Outlook: Contract Services' Crystal Ballalmost 2023 years ago
Virus Inactivation in the 1990s ? and into the 21st Century: Part 5: DisinfectionNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Implications of the First Liquid IV Infliximab Biosimilar
2
Risks, Resource Strain, and Trade-Offs in FDA’s CNPV Pilot Program
3
Why 503B Compounding Pharmacies Choose Prefabricated POD® Cleanrooms
4
The Switch to Cell-Free DNA: Strategic and Regulatory Considerations for Advanced Therapies
5
